Corrigendum: Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring - Molinos-Quintana, Águeda; Alonso-Saladrigues, Anna; Herrero, Blanca; Caballero-Velázquez, Teresa; Galán-Gómez, Víctor; Panesso, Melissa; Torrebadell, Montserrat; Delgado-Serrano, Javier; Pérez de Soto, Concepción; Faura, Anna; González-Martínez, Berta; Castillo-Robleda, Ana; et al. (Frontiers in Immunology, 2024)